Kaken Pharmaceutical Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY445.79 |
Market Cap |
JPY201.72 B |
Shares Outstanding |
45.94 M |
Public Float |
28.99 M |
Address |
2-28-8 Honkomagome Tokyo Tokyo 113 Japan |
Employees | - |
Website | http://www.kaken.co.jp |
Updated | 07/08/2019 |
Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. Its operations are carried out through the following business divisions: Pharmaceuticals and Medical Devices, Agrochemicals and Animal Health Products, Overseas Activity, Research & Development, and Licensing Opportunities. The Pharmaceuticals and Medical Devices division offers artz(anti-osteoarthritis), clenafin (topical onychomycosis treatment product), seprafilm (anti-adhesive absorbent barrier), lipidil (anti-hyperlipidemia product), fiblast spray (wound-healing product), mentax (anti-trichophyton product) and generic drugs. |